Skip Navigation LinksHome > March 2012 - Volume 7 - Issue 2 > HIV treatment as prevention and HPTN 052
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e32834f5cf2
TEST AND TREAT: Edited by Ann Duerr

HIV treatment as prevention and HPTN 052

Cohen, Myron S.a; McCauley, Marybethb; Gamble, Theresa R.c

Collapse Box

Abstract

Purpose of review: This review summarizes the development and implementation of a large clinical trial, HIV Prevention Trials Network (HPTN) 052, whose initial results were recently presented and published.

Recent findings: A randomized, clinical trial demonstrated that antiretroviral therapy reduces the sexual transmission of HIV in HIV-serodiscordant couples by more than 96%. The logistical challenges in preparing for and conducting such a trial were considerable.

Summary: HPTN 052 required many years of preparation, considerable collaboration between National Institute of Health and six pharmaceutical companies, and careful ongoing consideration of a large number of ethical issues. HPTN 052 revealed the magnitude of benefit when using antiretroviral therapy to prevent the transmission of HIV, and served as proof of a concept. The results have proven central to the development of new global HIV-prevention efforts.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.